CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002100 Tecon Biology Co.Ltd
- 6.35
- +0.11+1.76%
Market Closed Apr 30 15:00 CST
8.67BMarket Cap12.40P/E (TTM)
6.54High6.30Low519.74KlotVolume6.32Open6.24Pre Close332.84MTurnover3.81%Turnover Ratio14.33P/E (Static)1.37BShares8.7952wk High1.22P/B8.67BFloat Cap5.6752wk Low6.86Limit Up1.37BShs Float19.02Historical High5.62Limit Down3.85%Amplitude-0.32Historical Low--Dividend TTM6.40Avg Price240.16KlotAsk--Div YieldTTM100Lot Size251.69KlotBid
Tecon Biology Co.Ltd Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 21.28%3.25B | 9.93%3.1B | -5.06%3.65B | -25.54%2.86B | -31.02%2.68B | -15.00%2.82B | -35.08%3.84B | 57.11%3.84B | 67.53%3.89B | -3.05%3.32B |
| Transactional financial assets | 3,177.18%15.49M | 1,067.66%5.52M | --10.55M | -99.48%522.51K | --472.63K | -99.93%473.08K | ---- | --100M | ---- | --650.94M |
| Notes receivable and accounts receivable | -11.45%630.68M | 23.97%533.99M | -8.40%749.25M | -16.17%613.5M | -3.53%712.26M | 7.93%430.75M | 7.39%817.99M | 33.91%731.84M | 27.87%738.31M | 26.94%399.1M |
| -Notes receivable | 117.54%57.94M | 571.06%64.57M | 348.98%73.9M | -32.03%13.47M | 67.52%26.64M | -11.60%9.62M | 654.60%16.46M | 306.30%19.82M | 6.78%15.9M | 30.07%10.88M |
| -Accounts receivable | -16.47%572.73M | 11.47%469.43M | -15.74%675.36M | -15.73%600.02M | -5.09%685.63M | 8.48%421.13M | 5.53%801.54M | 31.46%712.02M | 28.43%722.41M | 26.86%388.22M |
| Other receivables (including interest and dividends) | 17.66%301.21M | 2.86%266.56M | 5.62%371.11M | -5.95%283.77M | -16.98%256M | -13.60%259.14M | 3.05%351.37M | -2.96%301.73M | -17.93%308.36M | -8.72%299.94M |
| -Other receivable | ---- | ---- | ---- | -5.95%283.77M | ---- | -13.60%259.14M | ---- | -2.96%301.73M | ---- | -8.72%299.94M |
| Advance payment | 36.20%659.93M | 116.45%836.72M | 131.55%862.5M | -20.41%316.22M | -27.30%484.52M | -65.96%386.57M | -52.75%372.48M | -23.27%397.31M | -24.24%666.45M | 42.71%1.14B |
| Inventories | 3.21%4.89B | 0.87%4.59B | -7.40%3B | -15.59%4.32B | -30.13%4.74B | -24.63%4.55B | -17.73%3.24B | -0.22%5.12B | 16.73%6.78B | 15.07%6.04B |
| Receivable financing | --3.96M | -99.38%84K | --11.28M | --2.29M | ---- | 397.94%13.53M | ---- | ---- | ---- | 1,371.03%2.72M |
| Other current assets | -0.88%475.72M | 0.70%479.24M | 24.20%414.37M | 2.55%483.24M | -19.20%479.93M | -11.04%475.88M | -17.10%333.62M | -4.24%471.21M | 14.09%593.93M | 7.35%534.95M |
| Total current assets | 9.48%10.24B | 9.90%9.85B | 1.71%9.12B | -18.97%8.9B | -27.97%9.36B | -27.71%8.96B | -26.23%8.96B | 16.21%10.98B | 23.87%12.99B | 16.81%12.4B |
| Non Current assets | ||||||||||
| Long-term equity investment | -31.16%25.7M | -7.80%33.29M | -13.59%33.56M | -12.16%33.83M | 74.83%37.34M | -65.76%36.11M | -70.76%38.84M | -69.39%38.51M | -82.80%21.36M | -2.43%105.45M |
| Fixed assets | ---- | ---- | ---- | 3.84%5.28B | ---- | 4.05%5.33B | ---- | 3.70%5.08B | ---- | 18.10%5.13B |
| Constru in process | ---- | ---- | ---- | 0.69%842.66M | ---- | 91.63%814.7M | ---- | 86.76%836.88M | ---- | -52.47%425.14M |
| Productive biological assets | -6.13%277.45M | -15.07%272.43M | -22.75%280.75M | -19.38%292.7M | -22.07%295.55M | -10.65%320.76M | -5.62%363.42M | -17.58%363.08M | -7.13%379.26M | 0.79%359M |
| Intangible assets | -3.09%372.88M | 4.52%377.17M | 15.56%389.63M | 13.12%385.71M | 40.79%384.78M | 34.44%360.84M | 22.89%337.17M | 22.06%340.96M | -2.63%273.3M | -1.36%268.4M |
| Development expenditure | 15.65%7.18M | 1.96%7.15M | -65.10%3.16M | -89.57%750K | -52.15%6.21M | -9.52%7.01M | -82.06%9.06M | -85.09%7.19M | -55.59%12.98M | --7.75M |
| Goodwill | -7.09%165.82M | -7.09%165.82M | -17.02%178.48M | -17.02%178.48M | -47.96%178.48M | 702.42%178.48M | 867.07%215.1M | 867.07%215.1M | 1,441.92%342.96M | 0.00%22.24M |
| Long deferred expense | 0.70%23.61M | -19.58%19.33M | -13.80%18.86M | -3.74%20.84M | 12.31%23.45M | 4.18%24.04M | -3.02%21.88M | -15.07%21.65M | -7.11%20.87M | -11.83%23.08M |
| Deferred tax assets | 46.97%108.92M | 37.35%99.14M | 101.40%92.26M | 172.55%74.66M | 72.12%74.12M | 84.56%72.18M | 154.77%45.81M | 49.64%27.39M | 115.31%43.06M | 143.58%39.11M |
| Usufruct assets | -17.69%536.76M | -7.12%579.26M | 5.35%608.22M | 13.07%631.36M | 16.12%652.15M | 14.91%623.65M | 15.81%577.34M | 18.20%558.38M | 15.15%561.64M | 10.90%542.71M |
| Other non current assets | 11,010.49%29.97M | 97.69%38.22M | -30.29%29.23M | -57.13%17.97M | -99.20%269.78K | -58.77%19.34M | --41.93M | --41.92M | --33.69M | 3,561.01%46.9M |
| Total non current assets | -3.27%7.55B | -0.98%7.71B | 1.98%7.81B | 2.96%7.75B | 5.76%7.81B | 11.84%7.79B | 12.32%7.65B | 11.09%7.53B | 11.83%7.38B | 6.73%6.97B |
| Total assets | 3.68%17.8B | 4.84%17.56B | 1.84%16.92B | -10.05%16.65B | -15.75%17.17B | -13.48%16.75B | -12.38%16.62B | 14.07%18.51B | 19.22%20.37B | 12.97%19.36B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -1.86%3.12B | -2.59%3.23B | 129.68%2.54B | 1.60%2.7B | -16.66%3.18B | 3.26%3.32B | -64.90%1.1B | -17.96%2.65B | 0.28%3.82B | -19.75%3.21B |
| Notes payable and accounts payable | -25.44%487.28M | -12.23%611.86M | -4.16%612.29M | 6.27%580.5M | 25.42%653.57M | 14.07%697.12M | 23.17%638.84M | 26.31%546.26M | -7.61%521.13M | 31.36%611.11M |
| -Notes payable | -81.68%3.86M | 99.93%10.59M | 76.47%14.85M | 463.86%23.79M | --21.08M | --5.3M | --8.41M | --4.22M | ---- | ---- |
| -Accounts payable | -23.57%483.41M | -13.09%601.27M | -5.23%597.44M | 2.71%556.71M | 21.37%632.49M | 13.21%691.82M | 21.55%630.42M | 25.33%542.04M | -7.61%521.13M | 31.36%611.11M |
| Contract liabilities | 85.45%892.79M | 51.21%665.66M | 112.15%735.34M | -32.28%498.67M | -1.51%481.41M | -6.82%440.23M | -33.47%346.61M | 28.67%736.36M | -35.85%488.79M | -30.64%472.48M |
| Advance receipts | --171.84K | 636.10%357.08K | ---- | ---- | ---- | -41.79%48.51K | ---- | ---- | ---- | -82.39%83.33K |
| Salaries payable | -6.77%249.51M | -14.33%254.91M | -4.07%233.7M | -11.65%220.16M | -14.11%267.63M | -5.01%297.56M | -12.82%243.63M | -11.12%249.18M | 5.14%311.59M | -11.95%313.24M |
| Taxs payable | -31.32%27.96M | -22.02%24.78M | 18.11%33.92M | -54.90%9.1M | 66.33%40.72M | 29.09%31.78M | 172.86%28.72M | 29.46%20.18M | -10.61%24.48M | 32.71%24.62M |
| Other payable (including interest and dividends) | -6.68%646.98M | -4.48%698.55M | 0.10%769.96M | -8.81%693.75M | -29.92%693.29M | -0.38%731.35M | 5.82%769.22M | 14.02%760.8M | 77.35%989.22M | 21.62%734.11M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%48.3M | ---- | -85.94%2.92M |
| -Other payable | ---- | ---- | ---- | -2.63%693.75M | ---- | 0.02%731.35M | ---- | 15.12%712.5M | ---- | 25.45%731.19M |
| Non current liabilities due within one year | -31.98%1.16B | -41.82%865.9M | -52.08%1.09B | 4.99%1.6B | 57.44%1.71B | 104.82%1.49B | 277.40%2.27B | 102.89%1.53B | 93.94%1.08B | -2.00%726.68M |
| Other current liabilities | 69.23%111.71M | 71.26%139.26M | 148.26%150.54M | -19.90%64.23M | -15.17%66.01M | -23.21%81.31M | -8.18%60.64M | 20.84%80.2M | 0.57%77.81M | 17.06%105.9M |
| Total current liabilities | -5.56%6.7B | -8.36%6.49B | 12.73%6.16B | -3.16%6.36B | -3.00%7.1B | 14.16%7.09B | -7.12%5.47B | 8.98%6.57B | 8.84%7.32B | -10.95%6.21B |
| Current liabilities | ||||||||||
| Long term loan | 27.18%1.98B | 67.90%2.06B | -7.55%1.64B | -41.99%1.48B | -45.79%1.56B | -60.89%1.23B | -38.60%1.77B | 24.82%2.55B | 27.68%2.88B | 59.52%3.13B |
| Estimate liabilities | --6.42M | --6.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -0.60%17.57M | -2.83%17.62M | 7.65%17.82M | 2,310.20%17.22M | 2,374.31%17.68M | 2,020.24%18.13M | 4,135.14%16.55M | 82.80%714.38K | 82.80%714.38K | 14.46%855.3K |
| Long term deferred income | -1.93%141.76M | 0.90%144.58M | 29.47%141.35M | 48.88%144.51M | 60.50%144.54M | 63.74%143.29M | 30.71%109.17M | 26.18%97.07M | 17.40%90.06M | 8.01%87.51M |
| Lease liabilities | -27.17%298.17M | -11.24%322.12M | 5.83%480.09M | 32.60%494.54M | 27.32%409.42M | 19.96%362.93M | 26.62%453.64M | 6.28%372.97M | -5.91%321.55M | 2.70%302.53M |
| Total non current liabilities | 14.84%2.45B | 45.63%2.55B | -3.14%2.28B | -29.32%2.14B | -35.21%2.13B | -50.35%1.75B | -31.23%2.35B | 17.89%3.02B | 18.98%3.29B | 44.72%3.52B |
| Total liabilities | -0.85%9.15B | 2.33%9.04B | 7.95%8.44B | -11.40%8.5B | -13.00%9.23B | -9.20%8.84B | -15.98%7.82B | 11.64%9.6B | 11.79%10.61B | 3.46%9.73B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.37B | 0.00%1.37B | 0.76%1.37B | 0.77%1.37B | 0.79%1.37B | 0.81%1.37B | 0.05%1.36B | 0.04%1.35B | 0.04%1.35B | 0.04%1.35B |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | -6.48%3.37M | -4.89%3.45M | -4.55%3.52M | -4.47%3.6M |
| Capital reserve funds | 0.00%3.94B | 0.00%3.94B | 0.70%3.94B | 0.75%3.94B | 0.15%3.94B | 2.60%3.94B | 3.02%3.91B | 18.49%3.91B | 19.24%3.94B | 16.34%3.84B |
| Surplus reserve funds | 0.00%466.77M | 0.00%466.77M | 6.31%466.77M | 6.31%466.77M | 6.31%466.77M | 6.31%466.77M | 58.80%439.08M | 58.80%439.08M | 58.80%439.08M | 59.69%439.08M |
| Retained profit | 110.02%1.33B | 104.07%1.19B | -22.38%1.11B | -44.74%823.8M | -72.26%635.46M | -74.39%581.39M | -42.16%1.43B | -29.79%1.49B | 6.50%2.29B | 4.73%2.27B |
| Other composite income | 667.52%9.85M | -0.11%51.06M | 1,117.36%54.99M | -54.34%10.28M | -115.39%-1.74M | 3,494.81%51.12M | 120.59%4.52M | 160.57%22.52M | 112.70%11.27M | 115.50%1.42M |
| Ordinary risk reserve funds | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 11.53%3.85M | 11.53%3.85M | 11.53%3.85M | 11.53%3.85M |
| Shareholders equity without minority interests | 11.09%7.12B | 9.44%7.02B | -2.91%6.95B | -8.51%6.61B | -20.25%6.41B | -19.01%6.41B | -9.38%7.15B | 2.86%7.23B | 14.83%8.04B | 11.52%7.92B |
| Minority interests | -0.03%1.53B | -0.02%1.5B | -6.59%1.53B | -8.89%1.54B | -11.69%1.53B | -12.28%1.5B | -6.76%1.64B | 178.21%1.69B | 187.09%1.73B | 170.08%1.71B |
| Total shareholder equity | 8.95%8.65B | 7.64%8.52B | -3.60%8.48B | -8.58%8.15B | -18.73%7.94B | -17.81%7.91B | -8.90%8.8B | 16.81%8.92B | 28.48%9.77B | 24.54%9.63B |
| Total liabilityies and equity | 3.68%17.8B | 4.84%17.56B | 1.84%16.92B | -10.05%16.65B | -15.75%17.17B | -13.48%16.75B | -12.38%16.62B | 14.07%18.51B | 19.22%20.37B | 12.97%19.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.